Abstract
A series of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential telomerase inhibitors were synthesized. The bioassay tests showed that compound 3b exhibited potentially high activity against human gastric cancer cell SGC-7901 with IC50 value was 2.98±0.16. Docking simulation was performed to position compound 3b into the telomerase (3DU6) active site to determine the probable binding model. The result shows that some coumarin containing 4,5-dihydropyrazole moiety can combine well with the telomerase active site and may have use as potential telomerase inhibitors.
Keywords: Coumarin, Dihydropyrazole, Molecular Docking, Antitumor Agent, Anticancer activity, Telomerase inhibitiors, Immortality, Ageing makes, Age-associated disorders, Human gastric cancer, Human liver cancer, Cytostatic properties, Cytotoxic activity, Mammalian cancer, Small bioactive molecule, CB1 antagonist, Docking simulation, Telomerase 3DU6, XT-4 binocular microscope, Pulse Fourier-transform NMR spectrometer, Analytical reagent-grade, Human gastric cell, Potent inhibitor, Telomerase, Binding mode, ATP binding site
Letters in Drug Design & Discovery
Title: Novel 3-(1-acetyl-5-(substituted-phenyl)-4,5-dihydro-1H-pyrazol-3-yl)-7-fluoro-2H-chromen-2-one Derivatives: Synthesis and Anticancer Activity
Volume: 7 Issue: 9
Author(s): Zheng-Yu Cai, Yang Yang, Xin-Hua Liu and Xing-Bao Qi
Affiliation:
Keywords: Coumarin, Dihydropyrazole, Molecular Docking, Antitumor Agent, Anticancer activity, Telomerase inhibitiors, Immortality, Ageing makes, Age-associated disorders, Human gastric cancer, Human liver cancer, Cytostatic properties, Cytotoxic activity, Mammalian cancer, Small bioactive molecule, CB1 antagonist, Docking simulation, Telomerase 3DU6, XT-4 binocular microscope, Pulse Fourier-transform NMR spectrometer, Analytical reagent-grade, Human gastric cell, Potent inhibitor, Telomerase, Binding mode, ATP binding site
Abstract: A series of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential telomerase inhibitors were synthesized. The bioassay tests showed that compound 3b exhibited potentially high activity against human gastric cancer cell SGC-7901 with IC50 value was 2.98±0.16. Docking simulation was performed to position compound 3b into the telomerase (3DU6) active site to determine the probable binding model. The result shows that some coumarin containing 4,5-dihydropyrazole moiety can combine well with the telomerase active site and may have use as potential telomerase inhibitors.
Export Options
About this article
Cite this article as:
Cai Zheng-Yu, Yang Yang, Liu Xin-Hua and Qi Xing-Bao, Novel 3-(1-acetyl-5-(substituted-phenyl)-4,5-dihydro-1H-pyrazol-3-yl)-7-fluoro-2H-chromen-2-one Derivatives: Synthesis and Anticancer Activity, Letters in Drug Design & Discovery 2010; 7 (9) . https://dx.doi.org/10.2174/157018010792929540
DOI https://dx.doi.org/10.2174/157018010792929540 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Assessment of Antioxidant Capacity of Natural Products
Current Pharmaceutical Biotechnology Interaction and Cytotoxic Effects of Hydrophobized Chitosan Nanoparticles on MDA-MB-231, HeLa and Arpe-19 Cell Lines
Current Topics in Medicinal Chemistry Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies
Current Pharmaceutical Design Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design Impact of Aging on the Angiogenic Potential of the Myocardium: Implications for Angiogenic Therapies with Emphasis on Sirtuin Agonists
Recent Patents on Cardiovascular Drug Discovery The Targeted-liposome Delivery System of Antitumor Drugs
Current Drug Metabolism Cisplatin Is a DNA-Damaging Antitumour Compound Triggering Multifactorial Biochemical Responses in Cancer Cells: Importance of Apoptotic Pathways
Current Medicinal Chemistry - Anti-Cancer Agents Design and Synthesis of Mannich bases as Benzimidazole Derivatives as Analgesic Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Niosomal Gel for Site-Specific Sustained Delivery of Anti-Arthritic Drug: In Vitro-In Vivo Evaluation
Current Drug Delivery Quantitative Structure-Activity Relationship Studies: Understanding the Mechanism of Tyrosine Kinase Inhibition
Current Enzyme Inhibition A Cross Sectional Study of Tumors Using Bio-Medical Imaging Modalities
Current Medical Imaging Does Immunohistochemistry Represent a Robust Alternative Technique in Determining Drugable Predictive Gene Alterations in Non-Small Cell Lung Cancer?
Current Drug Targets Biology of Cox-2: An Application in Cancer Therapeutics
Current Drug Targets Targeting Invasion Induction as a Therapeutic Strategy for the Treatment of Cancer
Current Cancer Drug Targets Mechanisms of Colon Cancer Prevention with and Beyond COX-2 Inhibition
Current Topics in Medicinal Chemistry Anorexia of Aging
Current Nutrition & Food Science IgG4-Related Disease (IgG4+MOLPS) – Diagnostic Criteria and Diagnostic Problems
Current Immunology Reviews (Discontinued) Endocytic Trafficking and Wnt/β-Catenin Signaling
Current Drug Targets Angiogenesis as a Therapeutic Target in Arthritis: Lessons from Oncology
Current Pharmaceutical Design Natural and Synthetic Agents Targeting Inflammation and Angiogenesis for Chemoprevention of Prostate Cancer
Current Cancer Drug Targets